Article
25 Jun 2026
The Case For Keeping AI Disputes Out Of Court
AUTHORS CONTENT
Article
19 May 2025
Arbitrating To Protect AI: Considerations For AI Companies When Adopting Arbitration Clauses
Article
17 Jan 2024
Issue 43: PTAB Trial Tracker
Article
16 Jan 2024
Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.
Article
16 Nov 2023
BYOOVIZ® (Ranibizumab-Nuna) Granted Interchangeable Status
Article
15 Aug 2022
Infliximab Clinical Trial Updates
Article
02 May 2022
FDA Testimony Before The U.S. Senate Regarding Reauthorization Of The Biosimilar User Fee Act